Anchor Investment Management, LLC Bristol Myers Squibb CO Transaction History

Anchor Investment Management, LLC

  • $1.06 Trillion
  • Q3 2024

A detailed history of Anchor Investment Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Anchor Investment Management, LLC holds 15,232 shares of BMY stock, worth $886,959. This represents 0.07% of its overall portfolio holdings.

Number of Shares
15,232
Previous 15,650 2.67%
Holding current value
$886,959
Previous $650 Million 21.25%
% of portfolio
0.07%
Previous 0.07%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 21, 2024
SELL
$39.66 - $51.75 $16,577 - $21,631
-418 Reduced 2.67%
15,232 $788 Million
Q2 2024

Sep 20, 2024
SELL
$40.25 - $52.99 $24,351 - $32,058
-605 Reduced 3.72%
15,650 $650 Million
Q1 2024

May 15, 2024
SELL
$47.98 - $54.4 $258,900 - $293,542
-5,396 Reduced 24.92%
16,255 $881 Million
Q4 2023

Jan 02, 2024
BUY
$48.48 - $57.85 $1.05 Million - $1.25 Million
21,651 New
21,651 $1.11 Billion
Q3 2023

Jan 02, 2024
BUY
$57.89 - $64.73 $26,629 - $29,775
460 Added 2.11%
22,279 $1.29 Billion
Q2 2023

Jan 02, 2024
BUY
$63.71 - $70.74 $65,111 - $72,296
1,022 Added 4.91%
21,819 $1.4 Billion
Q1 2023

Jan 02, 2024
BUY
$65.71 - $74.53 $34,826 - $39,500
530 Added 2.62%
20,797 $1.44 Billion
Q4 2022

Jan 02, 2024
SELL
$68.48 - $81.09 $94,776 - $112,228
-1,384 Reduced 6.39%
20,267 $1.46 Billion
Q3 2022

Jan 02, 2024
SELL
$0.13 - $76.84 $118 - $70,154
-913 Reduced 4.22%
20,738 $1.47 Billion
Q2 2022

Jan 02, 2024
SELL
$72.62 - $79.98 $4,938 - $5,438
-68 Reduced 0.34%
19,864 $1.53 Billion
Q1 2022

Jan 02, 2024
BUY
$61.48 - $73.72 $60,680 - $72,761
987 Added 5.21%
19,932 $1.46 Billion
Q4 2021

Jan 02, 2024
BUY
$53.63 - $62.52 $56,955 - $66,396
1,062 Added 5.94%
18,945 $1.18 Billion
Q3 2021

Jan 02, 2024
SELL
$59.17 - $69.31 $222,952 - $261,160
-3,768 Reduced 17.4%
17,883 $1.06 Billion
Q2 2021

Jan 02, 2024
BUY
$61.91 - $67.42 $153,536 - $167,201
2,480 Added 17.52%
16,632 $1.11 Billion
Q1 2021

Jan 02, 2024
BUY
$59.34 - $66.74 $247,447 - $278,305
4,170 Added 41.78%
14,152 $893 Million
Q4 2020

Jan 02, 2024
BUY
$57.74 - $65.43 $148,795 - $168,613
2,577 Added 34.8%
9,982 $619 Million
Q3 2020

Jan 02, 2024
SELL
$57.43 - $63.64 $818,147 - $906,615
-14,246 Reduced 65.8%
7,405 $446 Million
Q2 2020

Jan 02, 2024
BUY
$54.82 - $64.09 $112,381 - $131,384
2,050 Added 39.01%
7,305 $430 Million
Q1 2020

Jan 02, 2024
SELL
$46.4 - $67.43 $5,382 - $7,821
-116 Reduced 2.16%
5,255 $293 Million
Q4 2019

Jan 02, 2024
BUY
$49.21 - $64.19 $52,408 - $68,362
1,065 Added 24.73%
5,371 $345 Million
Q3 2019

Jan 02, 2024
SELL
$42.77 - $50.71 $741,845 - $879,564
-17,345 Reduced 80.11%
4,306 $218 Million
Q2 2019

Jan 02, 2024
BUY
$44.62 - $49.34 $4,060 - $4,489
91 Added 2.16%
4,306 $195 Million
Q1 2019

Jan 02, 2024
SELL
$45.12 - $53.8 $13,536 - $16,140
-300 Reduced 6.64%
4,215 $201 Million
Q4 2018

Jan 02, 2024
SELL
$48.76 - $63.23 $151,302 - $196,202
-3,103 Reduced 40.73%
4,515 $235 Million
Q3 2018

Jan 02, 2024
SELL
$55.19 - $62.25 $774,481 - $873,554
-14,033 Reduced 64.81%
7,618 $473 Million
Q2 2018

Jan 03, 2024
SELL
$50.53 - $62.98 $691,401 - $861,755
-13,683 Reduced 63.2%
7,968 $441 Million
Q1 2018

Jan 03, 2024
SELL
$59.92 - $68.98 $9,587 - $11,036
-160 Reduced 1.97%
7,968 $504 Million
Q2 2017

Jan 03, 2024
SELL
N/A
-13,523 Reduced 62.46%
8,128 $453 Million
Q1 2017

Jan 03, 2024
SELL
N/A
-150 Reduced 1.77%
8,328 $453 Million
Q4 2016

Jan 03, 2024
BUY
N/A
978 Added 13.04%
8,478 $495 Million
Q3 2016

Jan 03, 2024
BUY
N/A
300 Added 4.17%
7,500 $404 Million
Q2 2016

Jan 03, 2024
SELL
N/A
-14,451 Reduced 66.75%
7,200 $530 Million
Q1 2016

Jan 03, 2024
SELL
N/A
-15,301
6,350 $406 Million

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Anchor Investment Management, LLC Portfolio

Follow Anchor Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Anchor Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Anchor Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email